58
Growth Score in past quarter
pts
Heat Score 58 in past quarter
-17 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
244307
Tezcat Biosciences is committed to the research and development of novel biologic-based therapies to treat the most aggressive cancers.
- Craig Ramirez: CEO
- Andrew D. Hauser: Co-Founder and Research Scientist
About the Company
Tezcat Biosciences is committed to the research and development of novel biologic-based therapies to treat the most aggressive cancers. The first-generation technology has been optimized for tumor-specific killing, solid tumor penetration, and manufacturability. Born out of NYU Langone Health, our team is committed to refining and delivering the
leading-edge technology from bench to bedside.
Hispanic / Latine Founded
Hispanic / Latine Led